Report Categories
View AllRecent Articles
View All
Most 401k Participants Over 50 Shun Professional Advice Despite Wanting It
April Jobs Report Expected to Show Cooling Yet Resilient Labor Market
Shah Metacorp Penny Stock Retraces After Approaching 52Week High
Bayer CropScience Q4 Net Profit Rises 13 to 162 Crore on Revenue Growth
Prediction Markets Signal Potential Fed Rate Hike by July 2027
TFX Q1 2026 Earnings Earnings Beat Drives Modest Share Gain
AREC Q3 2025 Earnings NarrowerthanExpected Loss Drives Positive Sentiment
VSNT Q1 2026 Earnings Strong EPS Beat Highlights Profitability Focus
Kaltura Q1 2026 Earnings EPS Surges Past Estimates Amid Operational Efficiency
KZIA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline
Himalaya Shipping Ltd HSHP Declines 6 as Selling Pressure Challenges Support Levels
Crane Harbor Acquisition Corp Rights CHACR Surges 1728 as Rights Trading Gains Momentum
Shoulder Innovations Inc SI Slips 33 as Stock Tests Key Support Zone
MasterBrand Inc MBC Edges Higher as Stock Tests Key Resistance Near 81
Prediction Market Suggests SpaceX OpenAI Could Surpass Berkshire Hathaway in Market Value on Debut
China AI Systems Snub of Japanese Officials Condolences Raises Geopolitical Concerns for Tech Sector
2025s Top 10 Megamergers Reshape Global Industries A Review
Fed Dissenters Oppose Signaling Next Move Would Be a Rate Cut
External Links
Sacramento Takes Formal Step Toward Pursuing MLB Expansion Franchise
Tao Synergies Inc TAOX Q4 2024 Earnings EPS Misses Estimates as Shares Slide
PFH Sees Modest Uptick as FixedIncome Investors Assess Rate Outlook
Willamette Valley Vineyards Preferred Stock WVVIP Declines 344 Tests Key Support Levels
Sanmina SANM Surges Over 5 Breaking Above Key Resistance Levels
SFL Corporation Ltd Slides 15 as Resistance Holds Firm at 1306
Expensify Inc EXFY Edges Higher Amid Consolidation Near Key Levels
Warrior Met Coal HCC Faces Selling Pressure as Shares Decline 124 Key Levels to Watch
PMV Pharmaceuticals PMVP Slips to 126 as Cautious Trading Puts Support to the Test
Allogene Therapeutics Edges Higher Testing Key Resistance at 21